Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-03-23FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for enalapril maleate and hydrochlorothiazide from Dr. Reddy's Laboratories Limited, expanding regul…
-
FDA approval · 2014-03-18FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for aliskiren hemifumarate from Prasco Laboratories, authorizing the drug to be marketed under this …
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension [Phase 3]
Phase 3 trial DORADO evaluating fixed doses of darusentan vs placebo in resistant hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension [Phase 3]
The update covers completion of the Phase 3 DORADO-AC trial evaluating optimized doses of darusentan versus an active control in resistant h…
-
CLINICAL_TRIALS research · 2014-03-18Clinical Trial Update: DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension [Phase 3]
Update on the long-term safety extension of the Darusentan Phase 3 DORADO study (DORADO-EX/DAR-311) in resistant hypertension, noting termin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-03-17FDA Approved: DIOVAN HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for DIOVAN HCT (valsartan/hydrochlorothiazide) from Novartis Pharmaceuticals Corporation. The action…
-
FDA approval · 2014-03-17FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA has approved a supplemental application for EXFORGE, the fixed-dose combination of amlodipine besylate and valsartan, submitted by N…
-
FDA approval · 2014-03-17FDA Approved: EXFORGE HCT — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE HCT, a fixed-dose triple combination of amlodipine, valsartan, and hydrochlorothiazi…
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia [Phase 3]
This document discusses a Phase 3 trial evaluating the efficacy and safety of co-administering telmisartan and rosuvastatin in hypertensive …
-
CLINICAL_TRIALS trial_result · 2014-03-14Clinical Trial Update: The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR) [Phase 4]
The HONOR Phase 4 trial comparing candesartan to losartan in hypertension with heart failure was terminated.
-
FDA approval · 2014-03-07FDA Approved: AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM — Original Application (Dr. Reddy's Laboratories Inc)
FDA approved the original application for a generic fixed-dose combination of amlodipine besylate and atorvastatin calcium from Dr. Reddy's …
-
FDA approval · 2014-03-06FDA Approved: SPIRONOLACTONE — Original Application (NorthStar Rx LLC)
The FDA approved NorthStar Rx LLC's Original Application for spironolactone (generic spironolactone).
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327) [Phase 3]
Phase 3 pediatric trial comparing losartan alone to losartan/hydrochlorothiazide in children with hypertension; the study was terminated and…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Assessment of Blood Pressure Control and Target Organ Damage in Patients With Chronic Kidney Disease and Hypertension -II
Clinical trial update evaluating blood pressure control and target organ damage in patients with chronic kidney disease and hypertension.
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Analyzing How Genetics May Affect Response to High Blood Pressure Medications
A completed trial examining whether genetic differences affect responses to hypertension medications. The study, sponsored by the University…
-
CLINICAL_TRIALS trial_result · 2014-03-03Clinical Trial Update: Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337) [Phase 3]
Phase 3 clinical trial assessing losartan in pediatric patients with hypertension; results have been posted.
-
FDA approval · 2014-02-28FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for a generic lisinopril and hydrochlorothiazide combination product from Lupin Pharmaceuticals, int…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD) [Phase 4]
Clinical trial update indicating completion of a Phase 4 study evaluating renal and systemic vascular resistance in patients with chronic ki…
-
FDA approval · 2014-02-26FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
FDA approved a supplemental application for the generic fixed-dose combination of lisinopril and hydrochlorothiazide (GSMS, Incorporated).
-
FDA approval · 2014-02-26FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic lisinopril and hydrochlorothiazide combination tablet from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: A Spanish Pillbox App for Elderly Patients Taking Multiple Medications [NA]
A completed clinical trial evaluating a Spanish pillbox app to help elderly patients manage medications for diabetes and hypertension.
-
FDA approval · 2014-02-26FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for a generic lisinopril and hydrochlorothiazide combination tablet.
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Antihypertensive Effect of Continuous Positive Airway Pressure in Resistant Hypertensive Patients With Sleep Apnea [Phase 4]
A Phase 4 trial evaluated the antihypertensive effect of continuous positive airway pressure (CPAP) in patients with resistant hypertension …
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Pharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone [Phase 1]
Phase 1 study evaluating pharmacokinetic interactions and safety of combining telmisartan with chlorthalidone in hypertension has completed.
-
FDA approval · 2014-02-25FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved an original application for a generic fixed-dose combination of telmisartan and hydrochlorothiazide by Alembic Pharmaceuticals …